VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57017191 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000059.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q57017191‏
024 ‎‡a 0000-0003-1067-6680‏ ‎‡2 orcid‏
024 ‎‡a 6603344030‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q57017191‏
100 0 ‎‡a M Garnica‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a M Garnica‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals‏
670 ‎‡a Author's Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance‏
670 ‎‡a Author's Cryopreservation of peripheral blood stem cell: the influence of cell concentration on cellular and hematopoietic recovery‏
670 ‎‡a Author's D-index and Prediction of Infection‏
670 ‎‡a Author's Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis‏
670 ‎‡a Author's Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing‏
670 ‎‡a Author's Emerging Fungal Infections‏
670 ‎‡a Author's Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil.‏
670 ‎‡a Author's Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients‏
670 ‎‡a Author's Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil.‏
670 ‎‡a Author's Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve‏
670 ‎‡a Author's Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.‏
670 ‎‡a Author's Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients‏
670 ‎‡a Author's Risk factors for unsuccessful peripheral blood stem cell harvesting using granulocyte-colony stimulating factor mobilization in patients with multiple myeloma‏
670 ‎‡a Author's Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis‏
670 ‎‡a Author's Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma‏
909 ‎‡a (scopus) 6603344030‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000310676680‏ ‎‡9 1‏
919 ‎‡a epidemiologyofcandidemiainpatientswithhematologicmalignanciesandsolidtumoursinbrazil‏ ‎‡A Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil.‏ ‎‡9 1‏
919 ‎‡a earlierdiagnosisofinvasivefusariosiswithaspergillusserumgalactomannantesting‏ ‎‡A Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing‏ ‎‡9 1‏
919 ‎‡a difficultmycosesoftheskinadvancesintheepidemiologyandmanagementofeumycetomaphaeohyphomycosisandchromoblastomycosis‏ ‎‡A Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis‏ ‎‡9 1‏
919 ‎‡a 500indexandpredictionofinfection‏ ‎‡A D-index and Prediction of Infection‏ ‎‡9 1‏
919 ‎‡a cryopreservationofperipheralbloodstemcelltheinfluenceofcellconcentrationoncellularandhematopoieticrecovery‏ ‎‡A Cryopreservation of peripheral blood stem cell: the influence of cell concentration on cellular and hematopoietic recovery‏ ‎‡9 1‏
919 ‎‡a ciprofloxacinprophylaxisinhighriskneutropenicpatientseffectsonoutcomesantimicrobialtherapyandresistance‏ ‎‡A Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance‏ ‎‡9 1‏
919 ‎‡a candidaglabrataanemergingpathogeninbraziliantertiarycarehospitals‏ ‎‡A Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals‏ ‎‡9 1‏
919 ‎‡a emergingfungalinfections‏ ‎‡A Emerging Fungal Infections‏ ‎‡9 1‏
919 ‎‡a thalidomideplusdexamethasoneasamaintenancetherapyafterautologoushematopoieticstemcelltransplantationimprovesprogressionfreesurvivalinmultiplemyeloma‏ ‎‡A Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma‏ ‎‡9 1‏
919 ‎‡a superficialskinlesionspositiveforfusariumareassociatedwithsubsequentdevelopmentofinvasivefusariosis‏ ‎‡A Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis‏ ‎‡9 1‏
919 ‎‡a riskfactorsforunsuccessfulperipheralbloodstemcellharvestingusinggranulocytecolonystimulatingfactormobilizationinpatientswithmultiplemyeloma‏ ‎‡A Risk factors for unsuccessful peripheral blood stem cell harvesting using granulocyte-colony stimulating factor mobilization in patients with multiple myeloma‏ ‎‡9 1‏
919 ‎‡a prophylacticmeropenemduringneutropeniainallogeneicstemcelltransplantrecipients‏ ‎‡A Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients‏ ‎‡9 1‏
919 ‎‡a invasivefungaldiseasesinhaematopoieticcelltransplantrecipientsandinpatientswithacutemyeloidleukaemiaormyelodysplasiainbrazil‏ ‎‡A Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.‏ ‎‡9 1‏
919 ‎‡a indextopredictinvasivemoldinfectioninhighriskneutropenicpatientsbasedontheareaovertheneutrophilcurve‏ ‎‡A Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve‏ ‎‡9 1‏
919 ‎‡a increasedincidenceofinvasivefusariosiswithcutaneousportalofentrybrazil‏ ‎‡A Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil.‏ ‎‡9 1‏
919 ‎‡a factorsassociatedwithbacteremiaduetomultidrugresistantgramnegativebacilliinhematopoieticstemcelltransplantrecipients‏ ‎‡A Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients‏ ‎‡9 1‏
996 ‎‡2 SUDOC|242158781
996 ‎‡2 BNC|981061044673006706
996 ‎‡2 NTA|413635473
996 ‎‡2 SUDOC|144523973
996 ‎‡2 LC|n 2002109143
996 ‎‡2 LC|n 2001003958
996 ‎‡2 ISNI|0000000497882555
996 ‎‡2 BNCHL|10000000000000000263760
996 ‎‡2 ISNI|0000000021540509
996 ‎‡2 LC|ns2012002263
996 ‎‡2 ISNI|0000000358459722
996 ‎‡2 BNE|XX1531481
996 ‎‡2 LC|no2017005359
996 ‎‡2 ISNI|000000006089887X
996 ‎‡2 NUKAT|nx2023717371
996 ‎‡2 BNE|XX845333
996 ‎‡2 BNC|981058522094606706
996 ‎‡2 ISNI|0000000034328857
996 ‎‡2 BNE|XX6436915
996 ‎‡2 ISNI|0000000052792581
996 ‎‡2 PLWABN|9812466194805606
996 ‎‡2 LC|n 79097526
996 ‎‡2 SUDOC|236853511
996 ‎‡2 BNCHL|10000000000000000164808
996 ‎‡2 SUDOC|241587646
996 ‎‡2 ISNI|0000000068003372
996 ‎‡2 LC|ns2015003567
996 ‎‡2 BNE|XX6375150
996 ‎‡2 DNB|1062514785
996 ‎‡2 RERO|A018109468
996 ‎‡2 LC|nr2004001746
996 ‎‡2 PTBNP|254012
996 ‎‡2 DNB|1159121354
996 ‎‡2 DNB|1119926645
996 ‎‡2 RERO|A016494992
996 ‎‡2 ISNI|0000000115571453
996 ‎‡2 SUDOC|071545123
996 ‎‡2 BNC|981058526375206706
996 ‎‡2 LC|ns2015003847
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏